Best VCs for Digital Health

134 venture capitalists actively investing in Digital Health.

134
Active VCs
0
Funds
0
Deals
#1Jun Wakabayashi

Venture Principal

AppWorks

Jun uses fund investments as ecosystem infrastructure: back locally connected or specialist managers, exchange market intelligence and diligence, create co-investment and follow-on capital paths, and

Not publicly disclosed for Beacon Funds commitments. AppWorks' direct-company strategy publishes US$200K to US$15M per deal from Seed through Series C; that range should not be applied to Jun's venture-fund investments.
Emerging ManagersVenture FundsSeed
#2Bryan Rosenblatt

Venture Partner

Craft Ventures

Bryan applies a growth, revenue, and marketplace lens shaped by building Reddit's New York revenue organization and Twitter's startup advertising business. His investments favor products that remove e

No personal check-size range is published. Craft invests from angel/seed through venture and growth; amounts in Bryan's investment announcements are total company rounds, not his personal or standard Craft checks.
AngelPre-SeedSeed
#3Alex Morgan

Partner

Khosla Ventures

Alex invests where computation, biology, and healthcare converge. His scientific and clinical background supports a systems view of biomarker discovery, therapeutics, diagnostics, personalized medicin

No personal check range is published. Khosla's Seed Fund supports science and business-model experiments, historically often with roughly $1M–$2M according to a 2020 firm interview, while its Main Fund covers early through later stages. These are firm-level references, not Alex's authority.
IncubationPre-SeedSeed
#4Arielle Rothman

Investor

BoxGroup

Arielle invests within BoxGroup's broad earliest-stage mandate. Her differentiated documented context is technical and translational: Harvard bioengineering research, founding a postpartum medical-dev

No reliable Arielle-specific check size is public. BoxGroup describes itself as an earliest-stage investor, but founders should confirm current round fit and allocation directly rather than relying on third-party range estimates.
Pre-seedSeedEarliest-stage company formation
#5Deena Shakir

Partner

Lux Capital

Deena backs transformative technologies that improve health, access and economic opportunity, often with extraordinary underdog founders attacking problems conventional pattern recognition overlooks.

Lux does not publish a dependable personal check range for Deena. Her investments span stages, including first institutional rounds and later healthcare financings; founders should confirm vehicle, initial ticket, ownership, reserves and stage fit with the partnership.
SeedSeries ASeries B
#6Jackie Vullinghs

Partner

AirTree Ventures (Web3)

Jackie backs Australia and New Zealand founders from very early product formation through scale. Her disclosed portfolio crosses AI and enterprise software, healthcare, fintech, consumer platforms, fu

Neither Airtree nor Jackie publishes her personal check range or decision authority. The firm is seed-first and supports companies through later stages; individual portfolio round totals do not reveal Airtree's allocation or Jackie's authority.
Pre-SeedSeedSeries A
#7Fanis Tsarouchis

Senior Principal

Big Pi Ventures

Fanis supports European technology scale-ups moving toward market leadership with growth capital plus operational and financial expertise. His background in TMT investment banking and as FlexCar's fin

Growth-fund level: Big Pi Growth I states that it leads with €7M–€20M+ per company. Big Pi's overall platform spans €0.5M–€30M across funds. Neither range is published as Fanis's personal allocation authority.
Series BSeries CGrowth Equity
#8Wendy Xiao

Partner

Northzone (Web3)

Wendy backs companies that change consumer behavior and expand the economic pie by capturing neglected externalities. She studies technology through people and behavior change, looking for a valuable

Not publicly disclosed. Northzone states that the firm invests from Seed through Growth and can remain a partner through pre-IPO; Wendy's current profile labels her personal focus as Early and says she likes to work with founders from as early as seed.
SeedSeries AEarly Stage
#9Panos Metsis

Partner

Big Pi Ventures

Panos leads growth investments in European technology companies that already show category leadership and can use €7M–€20M+ plus active operating support to scale internationally. His recent work emph

Growth-fund level: Big Pi Growth I states that it leads with €7M–€20M+ per company. Panos focuses on Series B+ growth investments; the published fund range is not a guarantee of his personal allocation authority for any deal.
Series BSeries CGrowth Equity
#10Natalie Bartlett

Venture Partner

GreyMatter

Natalie Bartlett invests or supports investments through GreyMatter's published strategy: Back early founders transforming mental health through better access, outcomes, infrastructure, science and ex

GreyMatter does not publish a standard current check-size range on its official site.
Pre-SeedSeedEarly Stage
#11Adina Davis

Partner

BoxGroup

Adina is an early-stage generalist with a publicly documented emphasis on B2B software, consumer internet, and fintech. Her operating background in e-commerce and recent visible interest in AI deploym

BoxGroup publicly invests up to $1M. Older third-party profiles place Adina's typical early-stage range around $250K–$500K, but founders should treat the firm's current $1M ceiling—not an old personal range—as authoritative.
Pre-SeedSeedSeries A
#12Claire Smilow

Partner

BoxGroup

Claire backs formation-stage technology companies as a BoxGroup generalist, with visible strength across enterprise and developer software, AI-native products, consumer experiences, and marketplaces.

BoxGroup publicly invests up to $1M. Some third-party directories show an older $250K–$500K personal range, but no current primary source confirms a separate personal allocation.
Pre-SeedSeedSeries A
#13Disha Karale

Investor

BoxGroup

Disha invests at the earliest stages with a differentiated mix of finance, neuroscience, biotech R&D, and prior growth-investing exposure. Her public investor profile points to AI, enterprise infrastr

BoxGroup publicly invests up to $1M. Third-party profiles estimate Disha's range at $500K–$1M, but no primary source confirms a personal range, so the firm ceiling is the safer planning assumption.
Pre-SeedSeedSeries A
#14Roy Rosin

Board Partner

First Round Capital

Roy spends most of his First Round time in healthcare, applying three decades of product, innovation, and care-delivery experience to companies that can materially improve lives. He favors practical e

Firm-level: First Round says initial investments typically range from $1M-$7M, average about $3.5M, and have ranged below and above that; participating rounds have ranged from $100K-$20M.
Pre-SeedSeed
#15Alexis Johnson

Chief of Staff

HealthX Ventures

Alexis Johnson contributes to HealthX Ventures's published strategy: Lead seed equity rounds in scalable digital-health companies and actively help with healthcare customers, teams, operations and syn

HealthX Ventures does not publish a standard check-size range on its current official website.
Pre-RevenueSeedEarly Stage
#16Kayla Liederbach

Fractional Head of Marketing

HealthX Ventures

Kayla Liederbach contributes to HealthX Ventures's published strategy: Lead seed equity rounds in scalable digital-health companies and actively help with healthcare customers, teams, operations and s

HealthX Ventures does not publish a standard check-size range on its current official website.
Pre-RevenueSeedEarly Stage
#17Emma Merrick

Associate

HealthX Ventures

Emma Merrick contributes to HealthX Ventures's published strategy: Lead seed equity rounds in scalable digital-health companies and actively help with healthcare customers, teams, operations and syndi

HealthX Ventures does not publish a standard check-size range on its current official website.
Pre-RevenueSeedEarly Stage
#18Dan Neill

Venture Consultant

HealthX Ventures

Dan Neill contributes to HealthX Ventures's published strategy: Lead seed equity rounds in scalable digital-health companies and actively help with healthcare customers, teams, operations and syndicat

HealthX Ventures does not publish a standard check-size range on its current official website.
Pre-RevenueSeedEarly Stage
#19Sam Bogrov

Principal

Tau Ventures

Sam Bogrov invests or supports investments through Tau Ventures's published strategy: Partner early with founders applying AI to healthcare, enterprise workflows, automation and frontier technologies,

Tau Ventures does not publish a standard current check-size range on its live official site.
Pre-SeedSeedGrowth
#20Amit Garg

Founding Partner

Tau Ventures

Amit Garg invests or supports investments through Tau Ventures's published strategy: Partner early with founders applying AI to healthcare, enterprise workflows, automation and frontier technologies,

Tau Ventures does not publish a standard current check-size range on its live official site.
Pre-SeedSeedGrowth
#21Sanjay Rao

Founding Partner

Tau Ventures

Sanjay Rao invests or supports investments through Tau Ventures's published strategy: Partner early with founders applying AI to healthcare, enterprise workflows, automation and frontier technologies,

Tau Ventures does not publish a standard current check-size range on its live official site.
Pre-SeedSeedGrowth
#22Insoo Chang

Principal

Tau Ventures

Insoo Chang invests or supports investments through Tau Ventures's published strategy: Partner early with founders applying AI to healthcare, enterprise workflows, automation and frontier technologies

Tau Ventures does not publish a standard current check-size range on its live official site.
Pre-SeedSeedGrowth
#23Sharon Huang

Principal

Tau Ventures

Sharon Huang invests or supports investments through Tau Ventures's published strategy: Partner early with founders applying AI to healthcare, enterprise workflows, automation and frontier technologie

Tau Ventures does not publish a standard current check-size range on its live official site.
Pre-SeedSeedGrowth
#24Gary Ang

Venture Partner

Tau Ventures

Gary Ang invests or supports investments through Tau Ventures's published strategy: Partner early with founders applying AI to healthcare, enterprise workflows, automation and frontier technologies, w

Tau Ventures does not publish a standard current check-size range on its live official site.
Pre-SeedSeedGrowth
#25Larry Augustin

Venture Partner

Tau Ventures

Larry Augustin invests or supports investments through Tau Ventures's published strategy: Partner early with founders applying AI to healthcare, enterprise workflows, automation and frontier technolog

Tau Ventures does not publish a standard current check-size range on its live official site.
Pre-SeedSeedGrowth
#26Ravi Varma

Venture Partner

Tau Ventures

Ravi Varma invests or supports investments through Tau Ventures's published strategy: Partner early with founders applying AI to healthcare, enterprise workflows, automation and frontier technologies,

Tau Ventures does not publish a standard current check-size range on its live official site.
Pre-SeedSeedGrowth
#27Sonal Panda

Advisory Partner

Tau Ventures

Sonal Panda is listed in a Advisory Partner capacity at Tau Ventures. No person-specific investment thesis is published for this role; the firm's mandate is included only as shared context.

Tau Ventures does not publish a standard current check-size range on its live official site.
Pre-SeedSeedGrowth
#28Jim Adox

Managing Partner

Clarevia

Jim Adox invests or supports investments through Clarevia's published strategy: Back visionary healthcare entrepreneurs and breakthrough ideas that can improve patient lives, from therapeutic and devi

Clarevia does not publish a standard current check-size range on its official site.
SeedEarly StageGrowth
#29Scott Button

Partner

Clarevia

Scott Button invests or supports investments through Clarevia's published strategy: Back visionary healthcare entrepreneurs and breakthrough ideas that can improve patient lives, from therapeutic and

Clarevia does not publish a standard current check-size range on its official site.
SeedEarly StageGrowth
#30Paul Weiss

Partner

Clarevia

Paul Weiss invests or supports investments through Clarevia's published strategy: Back visionary healthcare entrepreneurs and breakthrough ideas that can improve patient lives, from therapeutic and de

Clarevia does not publish a standard current check-size range on its official site.
SeedEarly StageGrowth
#31David Arnstein

Partner and Chief Financial Officer

Clarevia

David Arnstein is listed in a Partner and Chief Financial Officer capacity at Clarevia. No person-specific investment thesis is published for this role; the firm's mandate is included only as shared c

Clarevia does not publish a standard current check-size range on its official site.
SeedEarly StageGrowth
#32John Neis

Partner

Clarevia

John Neis invests or supports investments through Clarevia's published strategy: Back visionary healthcare entrepreneurs and breakthrough ideas that can improve patient lives, from therapeutic and dev

Clarevia does not publish a standard current check-size range on its official site.
SeedEarly StageGrowth
#33Joe Amaral, MD

Chief Medical and Scientific Officer

Clarevia

Joe Amaral, MD is listed in a Chief Medical and Scientific Officer capacity at Clarevia. No person-specific investment thesis is published for this role; the firm's mandate is included only as shared

Clarevia does not publish a standard current check-size range on its official site.
SeedEarly StageGrowth
#34Jenni Le

Principal

Clarevia

Jenni Le invests or supports investments through Clarevia's published strategy: Back visionary healthcare entrepreneurs and breakthrough ideas that can improve patient lives, from therapeutic and devi

Clarevia does not publish a standard current check-size range on its official site.
SeedEarly StageGrowth
#35Margaret Kaczor Andrew

Venture Partner

Clarevia

Margaret Kaczor Andrew invests or supports investments through Clarevia's published strategy: Back visionary healthcare entrepreneurs and breakthrough ideas that can improve patient lives, from therap

Clarevia does not publish a standard current check-size range on its official site.
SeedEarly StageGrowth
#36Cheryl R. Blanchard, PhD

Executive in Residence

Clarevia

Cheryl R. Blanchard, PhD invests or supports investments through Clarevia's published strategy: Back visionary healthcare entrepreneurs and breakthrough ideas that can improve patient lives, from ther

Clarevia does not publish a standard current check-size range on its official site.
SeedEarly StageGrowth
#37Shelly Lanning

Venture Partner

Clarevia

Shelly Lanning invests or supports investments through Clarevia's published strategy: Back visionary healthcare entrepreneurs and breakthrough ideas that can improve patient lives, from therapeutic an

Clarevia does not publish a standard current check-size range on its official site.
SeedEarly StageGrowth
#38Becky Hoerman

Controller

Clarevia

Becky Hoerman is listed in a Controller capacity at Clarevia. No person-specific investment thesis is published for this role; the firm's mandate is included only as shared context.

Clarevia does not publish a standard current check-size range on its official site.
SeedEarly StageGrowth
#39Linda Olson

Office Manager

Clarevia

Linda Olson is listed in a Office Manager capacity at Clarevia. No person-specific investment thesis is published for this role; the firm's mandate is included only as shared context.

Clarevia does not publish a standard current check-size range on its official site.
SeedEarly StageGrowth
#40Danish Munir

Founding Partner

GreyMatter

Danish Munir invests or supports investments through GreyMatter's published strategy: Back early founders transforming mental health through better access, outcomes, infrastructure, science and experi

GreyMatter does not publish a standard current check-size range on its official site.
Pre-SeedSeedEarly Stage
#41Anna Wang

Principal

GreyMatter

Anna Wang invests or supports investments through GreyMatter's published strategy: Back early founders transforming mental health through better access, outcomes, infrastructure, science and experienc

GreyMatter does not publish a standard current check-size range on its official site.
Pre-SeedSeedEarly Stage
#42Andrew Barr

Founding Partner

GreyMatter

Andrew Barr invests or supports investments through GreyMatter's published strategy: Back early founders transforming mental health through better access, outcomes, infrastructure, science and experie

GreyMatter does not publish a standard current check-size range on its official site.
Pre-SeedSeedEarly Stage
#43David Schonthal

Operating Partner

7wire Ventures

David Schonthal is listed in a Operating Partner capacity at 7wire Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction an

7wire Ventures does not publish a standard current check-size range on its official site.
Pre-SeedSeedSeries A
#44Tom Richards

Operating Partner

7wire Ventures

Tom Richards is listed in a Operating Partner capacity at 7wire Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and u

7wire Ventures does not publish a standard current check-size range on its official site.
Pre-SeedSeedSeries A
#45Cameron Raglin

Senior Associate

7wire Ventures

Cameron Raglin invests or supports investments through 7wire Ventures's published strategy: Build and back early-stage digital-health companies that give informed, connected consumers more control and

7wire Ventures does not publish a standard current check-size range on its official site.
Pre-SeedSeedSeries A
#46Joslin Owens

Director of Finance

7wire Ventures

Joslin Owens is listed in a Director of Finance capacity at 7wire Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and

7wire Ventures does not publish a standard current check-size range on its official site.
Pre-SeedSeedSeries A
#47Sathya Shanthakumar

Director of Investor Relations

7wire Ventures

Sathya Shanthakumar is listed in a Director of Investor Relations capacity at 7wire Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that ro

7wire Ventures does not publish a standard current check-size range on its official site.
Pre-SeedSeedSeries A
#48Vivek Ranadivé

Founder and Managing Director

Bow Capital

Vivek Ranadivé is listed in a Founder and Managing Director capacity at Bow Capital. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distin

$5M average investment into core companies, as published by Bow Capital.
SeedSeries A
#49Murray Rode

General Partner

Bow Capital

Murray Rode invests or supports investments through Bow Capital's published strategy: Back founders building AI for the physical world across modern industry, defense, logistics and digital biology, u

$5M average investment into core companies, as published by Bow Capital.
SeedSeries A
#50Lynne Chou O'Keefe

Founder & Managing Partner

Define Ventures

Lynne Chou O'Keefe invests or supports investments through Define Ventures's published strategy: Back category-defining healthcare companies that combine deep ecosystem understanding with a technology

Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.
IncubationSeedSeries A
#51Bruce Broussard

Venture Partner

Define Ventures

Bruce Broussard invests or supports investments through Define Ventures's published strategy: Back category-defining healthcare companies that combine deep ecosystem understanding with a technology-dr

Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.
IncubationSeedSeries A
#52Frank Williams

Venture Partner

Define Ventures

Frank Williams invests or supports investments through Define Ventures's published strategy: Back category-defining healthcare companies that combine deep ecosystem understanding with a technology-dri

Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.
IncubationSeedSeries A
#53Carolyn Magill

Venture Partner

Define Ventures

Carolyn Magill invests or supports investments through Define Ventures's published strategy: Back category-defining healthcare companies that combine deep ecosystem understanding with a technology-dri

Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.
IncubationSeedSeries A
#54Karsten Vagner

Head of People

Define Ventures

Karsten Vagner is listed in a Head of People capacity at Define Ventures. This profile preserves that functional distinction; the firm's investment mandate is included only as shared context.

Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.
IncubationSeedSeries A
#55Shannon Knous

VP of Finance & Operations

Define Ventures

Shannon Knous is listed in a VP of Finance & Operations capacity at Define Ventures. This profile preserves that functional distinction; the firm's investment mandate is included only as shared contex

Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.
IncubationSeedSeries A
#56Lauren O'Mahony

Head of Marketing

Define Ventures

Lauren O'Mahony is listed in a Head of Marketing capacity at Define Ventures. This profile preserves that functional distinction; the firm's investment mandate is included only as shared context.

Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.
IncubationSeedSeries A
#57Katharine Morris

Administrative Assistant & Office Manager

Define Ventures

Katharine Morris is listed in a Administrative Assistant & Office Manager capacity at Define Ventures. This profile preserves that functional distinction; the firm's investment mandate is included onl

Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.
IncubationSeedSeries A
#58Alex Shandiz

General Partner

Boomerang Ventures

Alex Shandiz invests or supports investments through Boomerang Ventures's published strategy: Build and invest in connected-health companies improving care quality, access, delivery, efficiency and pa

Boomerang Ventures does not publish a standard current check-size range on its official site.
Pre-SeedSeedSeries A
#59Ariel MacTavish

Venture Partner

Boomerang Ventures

Ariel MacTavish invests or supports investments through Boomerang Ventures's published strategy: Build and invest in connected-health companies improving care quality, access, delivery, efficiency and

Boomerang Ventures does not publish a standard current check-size range on its official site.
Pre-SeedSeedSeries A
#60Audrey Beckman

Partner and Chief Innovation Officer

Boomerang Ventures

Audrey Beckman invests or supports investments through Boomerang Ventures's published strategy: Build and invest in connected-health companies improving care quality, access, delivery, efficiency and

Boomerang Ventures does not publish a standard current check-size range on its official site.
Pre-SeedSeedSeries A
#61Dick Aderman

Studio Director

Boomerang Ventures

Dick Aderman is listed in a Studio Director capacity at Boomerang Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and

Boomerang Ventures does not publish a standard current check-size range on its official site.
Pre-SeedSeedSeries A
#62Oscar Moralez

Founder and Managing Partner

Boomerang Ventures

Oscar Moralez invests or supports investments through Boomerang Ventures's published strategy: Build and invest in connected-health companies improving care quality, access, delivery, efficiency and p

Boomerang Ventures does not publish a standard current check-size range on its official site.
Pre-SeedSeedSeries A
#63Todd R. Lugar

Controller and HR Lead

Boomerang Ventures

Todd R. Lugar is listed in a Controller and HR Lead capacity at Boomerang Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinc

Boomerang Ventures does not publish a standard current check-size range on its official site.
Pre-SeedSeedSeries A
#64Tony Petrucciani

Partner and Chief Financial Officer

Boomerang Ventures

Tony Petrucciani is listed in a Partner and Chief Financial Officer capacity at Boomerang Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves t

Boomerang Ventures does not publish a standard current check-size range on its official site.
Pre-SeedSeedSeries A
#65Ben Trumbull

Managing Partner

Tamarind Hill

Ben Trumbull invests or supports investments through Tamarind Hill's published strategy: Lead seed rounds for B2B healthcare companies with early product-market fit across decentralized care, care eco

$2M-$7M seed rounds, as published by Tamarind Hill.
SeedEarly Stage
#66Josh Buehler

Operating Partner

Tamarind Hill

Josh Buehler invests or supports investments through Tamarind Hill's published strategy: Lead seed rounds for B2B healthcare companies with early product-market fit across decentralized care, care eco

$2M-$7M seed rounds, as published by Tamarind Hill.
SeedEarly Stage
#67Christie Currie

Senior Associate

Tamarind Hill

Christie Currie invests or supports investments through Tamarind Hill's published strategy: Lead seed rounds for B2B healthcare companies with early product-market fit across decentralized care, care

$2M-$7M seed rounds, as published by Tamarind Hill.
SeedEarly Stage
#68Allison Weiland

Finance and Operations Manager

Tamarind Hill

Allison Weiland is listed in a Finance and Operations Manager capacity at Tamarind Hill. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role di

$2M-$7M seed rounds, as published by Tamarind Hill.
SeedEarly Stage
#69Bob Saunders

General Partner

OCA Ventures

Bob Saunders invests or supports investments through OCA Ventures's published strategy: Invest in U.S. and Canadian companies with dramatic growth potential, launched products and measurable early cus

$1M-$3M with follow-on capacity, as published by OCA Ventures.
SeedSeries ASeries B
#70Nick Schoewe

Vice Chairman and General Partner

OCA Ventures

Nick Schoewe invests or supports investments through OCA Ventures's published strategy: Invest in U.S. and Canadian companies with dramatic growth potential, launched products and measurable early cus

$1M-$3M with follow-on capacity, as published by OCA Ventures.
SeedSeries ASeries B
#71Kevin McQuillan

General Partner

OCA Ventures

Kevin McQuillan invests or supports investments through OCA Ventures's published strategy: Invest in U.S. and Canadian companies with dramatic growth potential, launched products and measurable early

$1M-$3M with follow-on capacity, as published by OCA Ventures.
SeedSeries ASeries B
#72Fahad Qureshi

Vice President, Accounting and Finance

OCA Ventures

Fahad Qureshi is listed in a Vice President, Accounting and Finance capacity at OCA Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that ro

$1M-$3M with follow-on capacity, as published by OCA Ventures.
SeedSeries ASeries B
#73Michelle Cao

Vice President, Investments

OCA Ventures

Michelle Cao invests or supports investments through OCA Ventures's published strategy: Invest in U.S. and Canadian companies with dramatic growth potential, launched products and measurable early cus

$1M-$3M with follow-on capacity, as published by OCA Ventures.
SeedSeries ASeries B
#74Manu Sharma

Vice President, Investments

OCA Ventures

Manu Sharma invests or supports investments through OCA Ventures's published strategy: Invest in U.S. and Canadian companies with dramatic growth potential, launched products and measurable early cust

$1M-$3M with follow-on capacity, as published by OCA Ventures.
SeedSeries ASeries B
#75Kelley Quinn

Finance and Operations Manager

OCA Ventures

Kelley Quinn is listed in a Finance and Operations Manager capacity at OCA Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distin

$1M-$3M with follow-on capacity, as published by OCA Ventures.
SeedSeries ASeries B
#76Waverly Deutsch

Operating Partner

OCA Ventures

Waverly Deutsch invests or supports investments through OCA Ventures's published strategy: Invest in U.S. and Canadian companies with dramatic growth potential, launched products and measurable early

$1M-$3M with follow-on capacity, as published by OCA Ventures.
SeedSeries ASeries B
#77Peter Ianlo

Chairman and Co-Founder

OCA Ventures

Peter Ianlo invests or supports investments through OCA Ventures's published strategy: Invest in U.S. and Canadian companies with dramatic growth potential, launched products and measurable early cust

$1M-$3M with follow-on capacity, as published by OCA Ventures.
SeedSeries ASeries B
#78Sarah Manasevit

Senior Associate

OCA Ventures

Sarah Manasevit invests or supports investments through OCA Ventures's published strategy: Invest in U.S. and Canadian companies with dramatic growth potential, launched products and measurable early

$1M-$3M with follow-on capacity, as published by OCA Ventures.
SeedSeries ASeries B
#79Leticia Martinez

Senior Executive Assistant

OCA Ventures

Leticia Martinez is listed in a Senior Executive Assistant capacity at OCA Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distin

$1M-$3M with follow-on capacity, as published by OCA Ventures.
SeedSeries ASeries B
#80Bill Trainor

Co-Founder and Partner

Mutual Capital Partners

Bill Trainor invests or supports investments through Mutual Capital Partners's published strategy: Partner with healthcare IT and medical-device companies outside major technology centers that have st

Mutual Capital Partners does not publish a standard current check-size range on its official site.
Early StageGrowth
#81Wayne Wallace

Co-Founder and Partner

Mutual Capital Partners

Wayne Wallace invests or supports investments through Mutual Capital Partners's published strategy: Partner with healthcare IT and medical-device companies outside major technology centers that have s

Mutual Capital Partners does not publish a standard current check-size range on its official site.
Early StageGrowth
#82Ally Thill

Project Leader

Boomerang Ventures

Ally Thill is listed in a Project Leader capacity at Boomerang Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and us

Boomerang Ventures does not publish a standard current check-size range on its official site.
Pre-SeedSeedSeries A
#83Ian Drury

Venture Partner

OCA Ventures

Ian Drury invests or supports investments through OCA Ventures's published strategy: Invest in U.S. and Canadian companies with dramatic growth potential, launched products and measurable early custom

$1M-$3M with follow-on capacity, as published by OCA Ventures.
SeedSeries ASeries B
#84Dan Clark

Venture Partner

Boomerang Ventures

Dan Clark invests or supports investments through Boomerang Ventures's published strategy: Build and invest in connected-health companies improving care quality, access, delivery, efficiency and patie

Boomerang Ventures does not publish a standard current check-size range on its official site.
Pre-SeedSeedSeries A
#85David Helmer

Partner

Boomerang Ventures

David Helmer invests or supports investments through Boomerang Ventures's published strategy: Build and invest in connected-health companies improving care quality, access, delivery, efficiency and pa

Boomerang Ventures does not publish a standard current check-size range on its official site.
Pre-SeedSeedSeries A
#86Eric Beier

Partner and Chief Medical Officer

Boomerang Ventures

Eric Beier invests or supports investments through Boomerang Ventures's published strategy: Build and invest in connected-health companies improving care quality, access, delivery, efficiency and pati

Boomerang Ventures does not publish a standard current check-size range on its official site.
Pre-SeedSeedSeries A
#87Tejas Vijh

Associate

Boomerang Ventures

Tejas Vijh invests or supports investments through Boomerang Ventures's published strategy: Build and invest in connected-health companies improving care quality, access, delivery, efficiency and pati

Boomerang Ventures does not publish a standard current check-size range on its official site.
Pre-SeedSeedSeries A
#88Mark Shary

Managing Partner

Tamarind Hill

Mark Shary invests or supports investments through Tamarind Hill's published strategy: Lead seed rounds for B2B healthcare companies with early product-market fit across decentralized care, care econo

$2M-$7M seed rounds, as published by Tamarind Hill.
SeedEarly Stage
#89Jim Dugan

Founding Managing Partner

OCA Ventures

Jim Dugan invests or supports investments through OCA Ventures's published strategy: Invest in U.S. and Canadian companies with dramatic growth potential, launched products and measurable early custom

$1M-$3M with follow-on capacity, as published by OCA Ventures.
SeedSeries ASeries B
#90Steve Shein

Principal

OCA Ventures

Steve Shein invests or supports investments through OCA Ventures's published strategy: Invest in U.S. and Canadian companies with dramatic growth potential, launched products and measurable early cust

$1M-$3M with follow-on capacity, as published by OCA Ventures.
SeedSeries ASeries B
#91John Dugan

Chairman Emeritus and Co-Founder

OCA Ventures

John Dugan invests or supports investments through OCA Ventures's published strategy: Invest in U.S. and Canadian companies with dramatic growth potential, launched products and measurable early custo

$1M-$3M with follow-on capacity, as published by OCA Ventures.
SeedSeries ASeries B
#92Dave Zyer

Venture Partner

OCA Ventures

Dave Zyer invests or supports investments through OCA Ventures's published strategy: Invest in U.S. and Canadian companies with dramatic growth potential, launched products and measurable early custom

$1M-$3M with follow-on capacity, as published by OCA Ventures.
SeedSeries ASeries B
#93John Barnard

MBA Intern

OCA Ventures

John Barnard invests or supports investments through OCA Ventures's published strategy: Invest in U.S. and Canadian companies with dramatic growth potential, launched products and measurable early cus

$1M-$3M with follow-on capacity, as published by OCA Ventures.
SeedSeries ASeries B
#94Rashika Rahman

Intern

OCA Ventures

Rashika Rahman invests or supports investments through OCA Ventures's published strategy: Invest in U.S. and Canadian companies with dramatic growth potential, launched products and measurable early c

$1M-$3M with follow-on capacity, as published by OCA Ventures.
SeedSeries ASeries B
#95Liz Todia Zambory

Principal

Mutual Capital Partners

Liz Todia Zambory invests or supports investments through Mutual Capital Partners's published strategy: Partner with healthcare IT and medical-device companies outside major technology centers that ha

Mutual Capital Partners does not publish a standard current check-size range on its official site.
Early StageGrowth
#96Will Brune

Senior Associate

Mutual Capital Partners

Will Brune invests or supports investments through Mutual Capital Partners's published strategy: Partner with healthcare IT and medical-device companies outside major technology centers that have stro

Mutual Capital Partners does not publish a standard current check-size range on its official site.
Early StageGrowth
#97Pamela York

Founder and Managing Partner

Capita3

At the firm level, Capita3 backs exceptional teams commercializing science- and evidence-backed deep technology, digital health, and healthcare innovation.

Not publicly specified on the official site
Pre-seedSeedSeries A
#98Sara Russick

Founder and Managing Partner

Capita3

At the firm level, Capita3 backs exceptional teams commercializing science- and evidence-backed deep technology, digital health, and healthcare innovation.

Not publicly specified on the official site
Pre-seedSeedSeries A
#99Kathy Tune

Managing Partner

Capita3

At the firm level, Capita3 backs exceptional teams commercializing science- and evidence-backed deep technology, digital health, and healthcare innovation.

Not publicly specified on the official site
Pre-seedSeedSeries A
#100Claire Sun

Associate

Capita3

At the firm level, Capita3 backs exceptional teams commercializing science- and evidence-backed deep technology, digital health, and healthcare innovation.

Not publicly specified on the official site
Pre-seedSeedSeries A
#101Mark Bakken

Managing Partner

HealthX Ventures

Mark Bakken contributes to HealthX Ventures's published strategy: Lead seed equity rounds in scalable digital-health companies and actively help with healthcare customers, teams, operations and syndic

HealthX Ventures does not publish a standard check-size range on its current official website.
Pre-RevenueSeedEarly Stage
#102Samantha McGrandy

Chief Financial Officer

HealthX Ventures

Samantha McGrandy contributes to HealthX Ventures's published strategy: Lead seed equity rounds in scalable digital-health companies and actively help with healthcare customers, teams, operations and

HealthX Ventures does not publish a standard check-size range on its current official website.
Pre-RevenueSeedEarly Stage
#103Darcey Nett

Partner

HealthX Ventures

Darcey Nett contributes to HealthX Ventures's published strategy: Lead seed equity rounds in scalable digital-health companies and actively help with healthcare customers, teams, operations and syndic

HealthX Ventures does not publish a standard check-size range on its current official website.
Pre-RevenueSeedEarly Stage
#104Brian Lindstrom

Partner

HealthX Ventures

Brian Lindstrom contributes to HealthX Ventures's published strategy: Lead seed equity rounds in scalable digital-health companies and actively help with healthcare customers, teams, operations and sy

HealthX Ventures does not publish a standard check-size range on its current official website.
Pre-RevenueSeedEarly Stage
#105Laura Hilty

Principal

HealthX Ventures

Laura Hilty contributes to HealthX Ventures's published strategy: Lead seed equity rounds in scalable digital-health companies and actively help with healthcare customers, teams, operations and syndic

HealthX Ventures does not publish a standard check-size range on its current official website.
Pre-RevenueSeedEarly Stage
#106Shannon Flaherty

VP, Operations & Compliance

HealthX Ventures

Shannon Flaherty contributes to HealthX Ventures's published strategy: Lead seed equity rounds in scalable digital-health companies and actively help with healthcare customers, teams, operations and s

HealthX Ventures does not publish a standard check-size range on its current official website.
Pre-RevenueSeedEarly Stage
#107Jun Jeon

Partner

Khosla Ventures

Jun backs long-horizon technologies at the intersection of biology, healthcare and frontier engineering. His medical training, decade of bench and clinical research, digital-health operating work and

No reliable current personal check range was found. Khosla Ventures invests across company stages and is known for both early technical risk and later follow-on support, but founders should ask Jun about the applicable vehicle, initial ownership, reserves and decision process rather than relying on marketplace estimates.
Company FormationSeedSeries A
#108Hari Arul

Venture Partner

Khosla Ventures

Hari invests where technology can advance intelligence, security, infrastructure, and health. His founder/operator experience gives him a practical lens on regulated healthcare distribution, enterpris

Not publicly disclosed. Khosla Ventures uses a Seed Fund for experiments and a Main Fund for early-to-later rounds, including financings above $10M in total round size; round size is not the firm's or Hari's check size.
Pre-SeedSeedSeries A
#109Steven Tong

Partner

PEN Ventures

Steven brings accelerator, corporate innovation and venture experience across Southeast Asia, Australia/New Zealand and Korea. His disclosed investing track record includes 45 fintech and digital-heal

PEN Ventures does not publish a partner-specific or firm check-size range on its current website.
Pre-SeedSeedSeries A
#110Glen Tullman

Partner

7wire Ventures

Glen Tullman invests or supports investments through 7wire Ventures's published strategy: Build and back early-stage digital-health companies that give informed, connected consumers more control and i

7wire Ventures does not publish a standard current check-size range on its official site.
Pre-SeedSeedSeries A
#111Lee Shapiro

Partner

7wire Ventures

Lee Shapiro invests or supports investments through 7wire Ventures's published strategy: Build and back early-stage digital-health companies that give informed, connected consumers more control and im

7wire Ventures does not publish a standard current check-size range on its official site.
Pre-SeedSeedSeries A
#112Robert Garber

Partner

7wire Ventures

Robert Garber invests or supports investments through 7wire Ventures's published strategy: Build and back early-stage digital-health companies that give informed, connected consumers more control and

7wire Ventures does not publish a standard current check-size range on its official site.
Pre-SeedSeedSeries A
#113Alyssa Jaffee

Partner

7wire Ventures

Alyssa Jaffee invests or supports investments through 7wire Ventures's published strategy: Build and back early-stage digital-health companies that give informed, connected consumers more control and

7wire Ventures does not publish a standard current check-size range on its official site.
Pre-SeedSeedSeries A
#114Chuka Esiobu

Principal

Define Ventures

Chuka Esiobu invests or supports investments through Define Ventures's published strategy: Back category-defining healthcare companies that combine deep ecosystem understanding with a technology-drive

Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.
IncubationSeedSeries A
#115Garrett Howard

Principal

Define Ventures

Garrett Howard invests or supports investments through Define Ventures's published strategy: Back category-defining healthcare companies that combine deep ecosystem understanding with a technology-dri

Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.
IncubationSeedSeries A
#116Manveer Sandhu

Principal

Bow Capital

Manveer Sandhu invests or supports investments through Bow Capital's published strategy: Back founders building AI for the physical world across modern industry, defense, logistics and digital biology

$5M average investment into core companies, as published by Bow Capital.
SeedSeries A
#117Bill Evans

Founder and General Partner

Rock Health Capital

Bill Evans invests or supports investments through Rock Health Capital's published strategy: Invest in remarkable entrepreneurs working at the intersection of healthcare and technology to make healthc

Rock Health Capital does not publish a standard current check-size range on its official site.
SeedEarly Stage
#118Hylton Kalvaria

Advisor

Rock Health Capital

Hylton Kalvaria is listed in a Advisor capacity at Rock Health Capital. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and use

Rock Health Capital does not publish a standard current check-size range on its official site.
SeedEarly Stage
#119Keith W. Anderson

Advisor

Rock Health Capital

Keith W. Anderson is listed in a Advisor capacity at Rock Health Capital. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and u

Rock Health Capital does not publish a standard current check-size range on its official site.
SeedEarly Stage
#120Monique Smith

Advisor

Rock Health Capital

Monique Smith is listed in a Advisor capacity at Rock Health Capital. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses

Rock Health Capital does not publish a standard current check-size range on its official site.
SeedEarly Stage
#121Anish Aitharaju

Principal

7wire Ventures

Anish Aitharaju invests or supports investments through 7wire Ventures's published strategy: Build and back early-stage digital-health companies that give informed, connected consumers more control an

7wire Ventures does not publish a standard current check-size range on its official site.
Pre-SeedSeedSeries A
#122Guy Krief

Partner

Big Pi Ventures

Guy brings a founder-operator lens to Big Pi's multi-stage technology strategy. He is best matched with technically differentiated companies that can turn defensible IP into global products, especiall

€0.5M-€30M across Big Pi's family of funds, from seed and early stage through growth; this is a firm-level range.
SeedEarly StageGrowth
#123Erin Hardy

Accounting & Operations Manager

Define Ventures

Erin Hardy is listed in a Accounting & Operations Manager capacity at Define Ventures. This profile preserves that functional distinction; the firm's investment mandate is included only as shared cont

Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.
IncubationSeedSeries A
#124Chirag Shah

Partner

Define Ventures

Chirag Shah invests or supports investments through Define Ventures's published strategy: Back category-defining healthcare companies that combine deep ecosystem understanding with a technology-driven

Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.
IncubationSeedSeries A
#125Michael Wert

Partner

Define Ventures

Michael Wert invests or supports investments through Define Ventures's published strategy: Back category-defining healthcare companies that combine deep ecosystem understanding with a technology-drive

Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.
IncubationSeedSeries A
#126Rafi Syed

General Partner

Bow Capital

Rafi Syed invests or supports investments through Bow Capital's published strategy: Back founders building AI for the physical world across modern industry, defense, logistics and digital biology, usi

$5M average investment into core companies, as published by Bow Capital.
SeedSeries A
#127Hong Truong

Principal

Define Ventures

Hong Truong invests or supports investments through Define Ventures's published strategy: Back category-defining healthcare companies that combine deep ecosystem understanding with a technology-driven

Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.
IncubationSeedSeries A
#128Daven Patel

Partner

Bow Capital

Daven Patel invests or supports investments through Bow Capital's published strategy: Back founders building AI for the physical world across modern industry, defense, logistics and digital biology, u

$5M average investment into core companies, as published by Bow Capital.
SeedSeries A
#129Andre Ranadivé

Partner

Bow Capital

Andre Ranadivé invests or supports investments through Bow Capital's published strategy: Back founders building AI for the physical world across modern industry, defense, logistics and digital biology

$5M average investment into core companies, as published by Bow Capital.
SeedSeries A
#130Tiffany Yu

Principal

7wire Ventures

Tiffany Yu invests or supports investments through 7wire Ventures's published strategy: Build and back early-stage digital-health companies that give informed, connected consumers more control and imp

7wire Ventures does not publish a standard current check-size range on its official site.
Pre-SeedSeedSeries A
#131Sean Day

Principal

Rock Health Capital

Sean Day invests or supports investments through Rock Health Capital's published strategy: Invest in remarkable entrepreneurs working at the intersection of healthcare and technology to make healthcar

Rock Health Capital does not publish a standard current check-size range on its official site.
SeedEarly Stage
#132Ian Walker

Partner

Bow Capital

Ian Walker invests or supports investments through Bow Capital's published strategy: Back founders building AI for the physical world across modern industry, defense, logistics and digital biology, us

$5M average investment into core companies, as published by Bow Capital.
SeedSeries A
#133Eric Shan

Associate

7wire Ventures

Eric Shan invests or supports investments through 7wire Ventures's published strategy: Build and back early-stage digital-health companies that give informed, connected consumers more control and impr

7wire Ventures does not publish a standard current check-size range on its official site.
Pre-SeedSeedSeries A
#134James Chan

CFO

Bow Capital

James Chan is listed in a CFO capacity at Bow Capital. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mand

$5M average investment into core companies, as published by Bow Capital.
SeedSeries A

Explore more sectors

All SectorsDigital Health InvestmentsAll VCs